Subscribe to receive future Ambry updates!

Press Releases | Page 2

Wednesday Oct 19 2022

Ambry’s New Reproductive Health Program Uses Digital Platform to Make It Easier for Patients to Access Genetic Screening Before and During Pregnancy

Monday Aug 29 2022

Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have Been Missed by DNA Testing Alone

Wednesday Sep 15 2021

Konica Minolta Precision Medicine Announces Name Change to REALM IDx™

Wednesday Dec 16 2020

Ambry Genetics Named Best Company for Women and Workplace Culture

Tuesday Feb 25 2020

First Prospective Study Shows +RNAinsight™ Identifies More Patients with Increased Risk for Hereditary Cancer Than DNA-Only Testing

Monday Dec 16 2019

Ambry Genetics Receives New York State Approval to Offer Paired RNA and DNA Genetic Testing for Hereditary Cancer Risk

Tuesday Dec 10 2019

New Data from Ambry Genetics Showed Concurrent RNA and DNA Testing Identified More Patients with Hereditary Breast Cancer than DNA Testing Alone

Wednesday Dec 04 2019

Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

Tuesday Nov 05 2019

New Data from Ambry Genetics Show Substantial Increase in Diagnostic Yield, Further Supporting the Routine Use of RNA Genetic Testing for Hereditary Cancer Panels

Wednesday Oct 23 2019

Ambry Genetics Published Data that Finds Adding RNA Genetic Testing Provides More Accurate, Actionable Results for Patients who Receive DNA Testing for Hereditary Cancer Risk

Patients

Providers

Partners

CARE

Science

Company

Search Results

Start your search...